Data Concepts and Terminology Standards for Clinical Research and Drug Development (R24)

The FDA Center for Drug Evaluation and Research (CDER) is encouraging grant applications for programs to expedite development of data concepts and terminology to support human drug development and evaluation. The primary objective is to support the development of non-prietary, consensus-based, national data standards for use in clinical studies of human drugs and biologics. Projects may focus on solutions to general data standards development and implementation challenges or on specific clinical concepts or domains where standardization is needed.